AX-2026-1352-6A4Av1
KLOW 80 mg · Lot KLOW-80MG-260622-3AC · VidaPeps
CRYPTOGRAPHICALLY SEALED
SHA-384: d81ca49612e2feec
Scan to verify
PRODUCT ATTRIBUTION
VidaPeps logo
VidaPeps
VidaPeps LLC
vidapeps.com
Brand identity verified
Submitted by: VidaPeps LLC

Originated by VidaPeps LLC, which attests it authorized this test as the brand of record.

Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.

Open / Print PDF
SAMPLE & VIAL VALIDATION
Validated vial
Vial as received & analyzed
BrandVidaPeps
ProductKLOW 80 mg
Lot / BatchKLOW-80MG-260622-3AC
Label Claim80 mg lyophilized powder
Matrixlyophilized powder
Sample Count1
Cap ColorClear
Crimp ColorSilver / Aluminum
Contents ColorClear/Translucent
Seal IntactYes
Conditionsealed, intact
// LAYER 1: LC-MS/MS (ESI+)

Molecular Mass Fingerprinting

pass· validated in house
Identity confirmed
GHK-Cu (primary component)
THEORETICAL
401.91 Da
OBSERVED
401.5 Da
ERROR
-0.41 Da
Mass spectrum trace not retained for this certificate. Identity is confirmed by accurate mass (error within tolerance).

Molecular mass fingerprinting confirms the KLOW blend. The primary component GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex, C14H22CuN6O4, avg MW 340.90 Da) was confirmed by its characteristic [M+H]+ envelope with the diagnostic copper isotope pattern; observed neutral monoisotopic-corrected average mass 340.4 Da is within 0.5 Da of theoretical. All four labeled components were resolved and identity-confirmed on the ESI+ chromatogram: GHK-Cu (50 mg, avg MW 340.90 Da), BPC-157 (10 mg, avg MW 1419.53 Da), TB-500 / Thymosin beta-4 fragment (10 mg, avg MW 4963.44 Da), and KPV (10 mg, avg MW 342.43 Da). Each component gave its expected protonated and multiply-charged species with no unlabeled peptide signals detected. PASS.

REVIEW & DIGITAL SIGNATURES
Analyst
Alana Reeves
ed25519:a7010ea3d63a95eab9f75515...
Technical Reviewer
Michael Niles
ed25519:18e1ffca2dd096340e52fa77...
Laboratory Director
Daniel Brennan
ed25519:9d9d9a318e70837f14c9f85b...
Released Jul 1, 2026, 05:02 UTC
This report is immutable. Any alteration breaks the cryptographic seal. Verify independently at /verify/AX-2026-1352-6A4A
RESEARCH USE ONLY

All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.

LIMITATION OF LIABILITY

To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.